Anhui Biochem Bio-Pharmaceutical

Anhui Biochem Bio-Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of antiviral medications, particularly for HIV/AIDS and Hepatitis B. The company is a major global supplier of antiretroviral drugs, maintaining significant partnerships with international organizations such as the World Health Organization and the Clinton Health Access Initiative. Their vertically integrated operations encompass the production of both active pharmaceutical ingredients and finished dosage forms, ensuring high quality and cost-effectiveness. Anhui Biochem's manufacturing facilities are GMP-certified and have successfully passed inspections by various international regulatory bodies. The company's portfolio includes essential treatments like lamivudine, tenofovir, and dolutegravir, as well as fixed-dose combinations designed to improve patient compliance. Through its commitment to affordable medicine, Anhui Biochem plays a critical role in expanding access to life-saving treatments in emerging markets worldwide.